CAPTRUST Financial Advisors
PDSB icon

CAPTRUST Financial Advisors’s PDS Biotechnology PDSB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250
Closed -$1K – 3449
2022
Q2 		$1K Hold
250
– – ﹤0.01% 4717
2022
Q1 		$2K Buy
+250
New +$1.55K ﹤0.01% 4522

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

CAPTRUST Financial Advisors's PDSB Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of PDS Biotechnology (PDSB) in Q3 2022, closing a stake of 250 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in PDSB in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining PDS Biotechnology position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 250 PDS Biotechnology shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in PDS Biotechnology in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's PDS Biotechnology position peaked at $2K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.